Stocks to Buy in January 2025. Part II.


 

QuantumScape (QS)

Entry: Unlock

Price target: 7.20-7.30

Second PT: Unlock

Solid-state batteries are an advanced type of battery technology that use a solid electrolyte instead of the liquid or gel found in traditional lithium-ion batteries. They offer higher energy density, improved safety, longer lifespans, faster charging, and a more compact design, making them ideal for applications such as electric vehicles, consumer electronics, and renewable energy storage.

While they promise significant advantages, challenges such as high production costs, scalability, and certain durability issues remain. Solid-state batteries are regarded as a critical innovation for the future of energy storage and electrification.

Many companies are pursuing the development of solid-state batteries, with QuantumScape reportedly being the closest to commercialization, alongside Nio, which claims to have already developed semi-solid-state batteries. Battery and electric vehicle manufacturers worldwide are racing to perfect this technology, recognizing that mastering it could provide a decisive competitive advantage in the EV industry.  

It is important to note that many of these companies, including the three highlighted below, are either in a pre-revenue stage or generating only minimal early revenues. This makes them high-risk, high-reward investments in the industry. Investors interested in these companies should monitor new research and product development updates closely to evaluate their performance. In the short term, these companies have earned a spot on our watchlist following Tesla’s record-breaking EV delivery numbers last week, which brought renewed attention to the EV market overall.

Please note that this may take beyond this week to come around to price targets. 

BlackSky Technology (BKSY)

Entry: Unlock

Price target: 14.00-15.00

Second PT: Unlock

BlackSky Technology is a small-cap company that has been in operation since 2014, providing customers with vital satellite imagery and data to support better decision-making across various commercial and government projects. This space-based intelligence company delivers real-time imagery, analytics, and high-frequency monitoring of strategic locations, economic assets, and events. Its data is sold to interested parties, including the U.S. military.

Practical applications of its services include monitoring energy facilities to track global oil and energy reserves. BlackSky also uses satellite imagery to monitor ports, shipping containers, and major industrial sites, enabling the detection of changes and activities that could impact economic trends. It’s no surprise that Wall Street finds this technology intriguing, as it offers foresight into trends that could influence markets.

The company has secured numerous contracts recently, including a five-year contract with the National Geospatial-Intelligence Agency (NGA) valued at $290 million—nearly as much as the company’s entire market cap of $365 million. As these contracts accumulate and the race to space intensifies, BlackSky’s early presence in the industry gives it a competitive edge. For investors seeking a niche space investment, the company’s current valuation could represent a compelling opportunity.

Please note that this may take beyond this week to come around to price targets. 

Guardant Health (GH)

Entry: Unlock

Price target: 40.00-42.00

Second PT: Unlock

Cancer research and health services stocks saw a surge in volume last week following new warnings from the U.S. Surgeon General, highlighting a link between alcohol consumption and cancer. This announcement drove cancer research stocks higher and alcohol stocks lower, shifting investors' attention to health services companies to start the new year. One such company is Guardant Health, an oncology-focused organization developing proprietary cancer treatment solutions. Although Guardant Health (GH) operates in a competitive space, it earned a spot on our watchlist due to its strong financial performance and promising projections.

Over the past eight years, GH has grown its revenue tenfold, increasing from just under $50 million in 2017 to an anticipated $600+ million in 2025. While the company’s net income has remained negative, its advancements in cancer treatment signal significant potential for future revenue growth, which could eventually lead to profitability and positive free cash flow. One of Guardant’s products was recognized by Time Magazine as one of the best inventions of 2024, selected from among 200 technologies. The accolade specifically highlighted the company’s innovative use of artificial intelligence to deliver accurate test results.  

From a technical perspective, GH is a volatile stock with an uncertain trajectory, but recent price movements suggest it may be gearing up for another attempt at its 52-week highs. We’ll be watching for a breakout above $38.53 to signal bullish continuation toward our price targets.

Please note that this may take beyond this week to come around to price targets. 


You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click
here for more information. 



You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 



You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 



You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 



You've reached the end of our complimentary public watchlist. Unlock for the full list by becoming a member of our Hyper Stocks community. Click here for more information. 

___________________________________

The stocks posted above are the preliminary stocks and set ups we’ll be watching this week. All price points are subject to change based on market performance and sector health. Please do your own research and analysis on these companies/charts before taking on any set ups. Trade at your own risk and as always, good luck! Let’s have a fantastic week.